European Value Added of Chemical and Pharmaceutical Products by Country

Germany leads the European value-added of chemical and pharmaceutical products with 75.77 billion euros. France follows significantly at 35.54 billion euros, while Belgium, Spain, and the Netherlands constitute the mid-tier contributors with values ranging from 20.87 to 15.96 billion euros. Austria, Finland, and Greece show lower but notable figures. Estonia and Luxembourg have minimal contributions, less than 0.16 billion euros each.

Year-over-year analysis indicates Germany with a modest 1.01% growth, whereas Belgium (3.64%) and Greece (3.03%) exhibited the most significant annual growth rates in 2023 among the analyzed countries. Over the last five years, compound annual growth rates suggest steady expansions, with Belgium and Greece leading these trends.

Future trends to watch include the potential for increased value-added contributions from emerging markets within Europe, particularly in regions with current lower baselines. Continued investment in innovation, sustainability, and biopharmaceuticals may drive these emerging markets' growth, contributing to a more balanced distribution of value-added across Europe.